Comparison of outcomes with PD-L1 tumor proportion score (TPS) of 50-74% vs 75-100% in patients with non-small cell lung cancer (NSCLC) treated with first-line PD-1 inhibitors Meeting Abstract
| Authors: | Aguilar, E. J.; Rizvi, H.; Kravets, S.; Lydon, C. A.; Adeni, A. E.; Subegdjo, S.; Hellmann, M. D.; Awad, M. M. |
| Abstract Title: | Comparison of outcomes with PD-L1 tumor proportion score (TPS) of 50-74% vs 75-100% in patients with non-small cell lung cancer (NSCLC) treated with first-line PD-1 inhibitors |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 469s |
| Language: | English |
| ACCESSION: | WOS:000442916003211 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9037 |
| Notes: | Meeting Abstract: 9037 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work